Déi 26 Joer al Hollännerin hat de leschte Wanter 15 Coursse gewonnen, esou vill wéi keng aner Fra, dorënner de Weltcup zu Koksijde, de Superprestige zu Middelkerke an d’EKZ Cross Tour.
Wéinst hire gudde Resultater krut d’Denise Betsema nach wärend dem Wanter e Kontrakt bei der Ekipp Marlux-Bongoal. D’Ekipp huet nom positiven Test matgedeelt, datt d’Hollännerin vehement bestreit, verbuede Mëttel geholl ze hunn. Elo gëtt op d’Resultat vun der B-Prouf gewaart, bis dohinner ass d’Betsema suspendéiert.
Schreiwes vun der UCI:
Apr 5, 2019, 16:59 PM
The Union Cycliste Internationale (UCI) announces that the Dutch rider Denise Betsema was notified of an Adverse Analytical Finding (AAF) of Endogenous Anabolic Androgenic Steroid(s) administered exogenously in a sample collected on 27 January 2019 during the Telenet UCI Cyclo-cross World Cup in Hoogerheide, Netherlands.
This doping control was planned and carried out by the Cycling Anti-Doping Foundation (CADF), the independent body mandated by the UCI, in charge of defining and implementing the anti-doping strategy in cycling.
The rider has the right to request and attend the analysis of her B sample.
In accordance with UCI Anti-Doping Rules, the rider has been provisionally suspended until the adjudication of the procedure.
At this stage of the procedure, the UCI will not comment any further on the matter.
